Cumberland Pharmaceu (CPIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Sales | 36,902 | 32,028 | 48,851 | 51,143 | 45,876 |
| Cost of Goods | 5,053 | 5,439 | 5,046 | 5,363 | 3,587 |
| Gross Profit | 31,849 | 26,588 | 43,805 | 45,780 | 42,290 |
| Operating Expenses | 28,343 | 30,829 | 35,033 | 36,293 | 36,375 |
| Operating Income | 3,559 | -3,801 | 8,818 | 9,850 | 6,502 |
| Interest Expense | 67 | 103 | 72 | 354 | 1,424 |
| Other Income | 252 | 230 | 305 | 211 | 200 |
| Pre-tax Income | 3,743 | -3,675 | 9,051 | 9,707 | 5,278 |
| Income Tax | 1,381 | -1,523 | 3,245 | 4,080 | 2,851 |
| Net Income Continuous | 2,363 | -2,151 | 5,806 | 5,627 | 2,427 |
| Minority Interests | -61 | -47 | -36 | -31 | -30 |
| Net Income | $2,424 | $-2,105 | $5,843 | $5,658 | $2,457 |
| EPS Basic Total Ops | 0.14 | -0.11 | 0.30 | 0.28 | 0.12 |
| EPS Basic Continuous Ops | 0.13 | -0.12 | 0.30 | 0.28 | 0.12 |
| EPS Diluted Total Ops | 0.14 | -0.11 | 0.30 | 0.28 | 0.12 |
| EPS Diluted Continuous Ops | 0.13 | -0.12 | 0.29 | 0.27 | 0.12 |
| EBITDA(a) | $5,548 | $-2,500 | $9,720 | $10,890 | $7,480 |